Treatment of inflammatory or malignant disease using dnazymes

The present invention relates to DNAzymes which are targeted against mRNA molecules encoding RelA(p65) (a subunit of NF- kappa B). The present invention also relates to compositions including these DNAzymes and to methods of treatment involving administration of the DNAzymes.

Saved in:
Bibliographic Details
Main Authors MALCOLM LOVELL HANDEL, DAVID G. ATKINS, LY QUOC QUYHN NGUYEN
Format Patent
LanguageEnglish
Published 27.11.2002
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to DNAzymes which are targeted against mRNA molecules encoding RelA(p65) (a subunit of NF- kappa B). The present invention also relates to compositions including these DNAzymes and to methods of treatment involving administration of the DNAzymes.
Bibliography:Application Number: CN20008011262